Literature DB >> 24452445

Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.

Zhenhuan Jiang1, Jiannong Jiang2, Huilin Yang1, Zhijun Ge3, Qiang Wang2, Leiyan Zhang2, Chenguang Wu2, Jinzhi Wang4.   

Abstract

The overexpression of Aurora kinase A (AURKA), a member of serine/threonine kinase family, has been observed in various types of human cancers. However, the role of AURKA in osteosarcoma (OS), the most common type of primary malignancy arising from bone, has not been clarified. We used AURKA-specific lentivirus-delivered short hairpin RNA (shRNA) to significantly and sustainably silence the endogenous AURKA expression in human OS cells SAOS-2 and U2OS. We found that AURKA downregulation in OS cells prominently decreased colony formation ability in vitro and tumorigenesis ability in vivo. We further evaluated the effect of AURKA silence on cell viability by MTT assay, cell apoptosis and cell cycle by flow cytometer detection. The results showed that AURKA silence inhibited cell viability by inducing cell apoptosis and G2/M cell cycle arrest in OS cells. Taken together, our findings indicate that AURKA plays a crucial role on OS growth by inhibiting cell apoptosis and propelling cell cycle. Inhibition of AURKA by lentivirus-delivered specific shRNA showed the therapeutic potential in treatment of osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452445     DOI: 10.3892/or.2014.2986

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

Review 1.  Targeting protein kinases to reverse multidrug resistance in sarcoma.

Authors:  Hua Chen; Jacson Shen; Edwin Choy; Francis J Hornicek; Zhenfeng Duan
Journal:  Cancer Treat Rev       Date:  2015-12-08       Impact factor: 12.111

2.  Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.

Authors:  He Wang; Henghui Yin; Fengjiao Yan; Mingna Sun; Lingran Du; Wei Peng; Qiuli Li; Yinghong Feng; Yi Zhou
Journal:  Oncotarget       Date:  2015-02-20

Review 3.  Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma.

Authors:  Atik Badshah Shaikh; Fangfei Li; Min Li; Bing He; Xiaojuan He; Guofen Chen; Baosheng Guo; Defang Li; Feng Jiang; Lei Dang; Shaowei Zheng; Chao Liang; Jin Liu; Cheng Lu; Biao Liu; Jun Lu; Luyao Wang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-04-06       Impact factor: 5.923

4.  Continuous treatment with FTS confers resistance to apoptosis and affects autophagy.

Authors:  Eran Schmukler; Eya Wolfson; Zvulun Elazar; Yoel Kloog; Ronit Pinkas-Kramarski
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

5.  Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.

Authors:  Hao Shen; Wei Wang; Bingbing Ni; Qiang Zou; Hua Lu; Zhanchao Wang
Journal:  Int J Mol Med       Date:  2018-03-27       Impact factor: 4.101

6.  Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells.

Authors:  Yu Mao; Yimin Wang; Lixin Dong; Yunjie Zhang; Yanqiu Zhang; Chao Wang; Qiang Zhang; Sen Yang; Liyan Cao; Xinyuan Zhang; Xin Li; Zhanzhao Fu
Journal:  J Exp Clin Cancer Res       Date:  2019-09-05

7.  Screening of Long Noncoding RNAs Induced by Radiation Using Microarray.

Authors:  Yilong Wang; Qi Wang; Shuangjing Chen; Yingchun Hu; Chang Yu; Ruixue Liu; Zhidong Wang
Journal:  Dose Response       Date:  2020-04-06       Impact factor: 2.658

8.  Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines.

Authors:  Xiao-Rong Yang; Yan Xiong; Hong Duan; Ren-Rong Gong
Journal:  J Orthop Surg Res       Date:  2015-09-04       Impact factor: 2.359

9.  Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.

Authors:  Edmilson Ozorio Dos Santos; Tatiana Correa Carneiro-Lobo; Mateus Nobrega Aoki; Elena Levantini; Daniela Sanchez Bassères
Journal:  Mol Cancer       Date:  2016-02-03       Impact factor: 27.401

10.  MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation.

Authors:  Zuzanna Baranski; Tijmen H Booij; Marieke L Kuijjer; Yvonne de Jong; Anne-Marie Cleton-Jansen; Leo S Price; Bob van de Water; Judith V M G Bovée; Pancras C W Hogendoorn; Erik H J Danen
Journal:  Genes Cancer       Date:  2015-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.